期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Pregnancy related issues in inflammatory bowel disease: Evidence base and patients' perspective 被引量:2
1
作者 Christian P Selinger Rupert WL Leong simon lal 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第21期2600-2608,共9页
Inflammatory bowel disease (IBD) affects women of childbearing age and can influence fertility, pregnancy and decisions regarding breastfeeding. Women with IBD need to consider the possible course of disease during pr... Inflammatory bowel disease (IBD) affects women of childbearing age and can influence fertility, pregnancy and decisions regarding breastfeeding. Women with IBD need to consider the possible course of disease during pregnancy, the benefits and risks associated with medications required for disease management during pregnancy and breastfeeding and the effects of mode of delivery on their disease. When indicated, aminosalicylates and thiopurines can be safely used during pregnancy. Infliximab and Adalimumab are considered probably safe during the first two trimesters. During the third trimester the placenta can be crossed and caution should be applied. Methotrexate is associated with severe teratogenicity due to its folate antagonism and is strictly contraindicated. Women with IBD tend to deliver earlier than healthy women, but can have a vaginal delivery in most cases. Caesarean sections are generally recommended for women with active perianal disease or after ileo-anal pouch surgery. While the impact of disease activity and medication has been addressed in several studies, there are minimal studies evaluating patients' perspective on these issues. Women's attitudes may influence their decision to have children and can positively or negatively influence the chance of conceiving, and their beliefs regarding therapies may impact on the course of their disease during pregnancy and/or breastfeeding. This review article outlines the impact of IBD and its treatment on pregnancy, and examines the available data on patients' views on this subject. 展开更多
关键词 怀孕期间 鸡传染性法氏囊病 回肠 炎症 基础 证据 安全使用 氨基水杨酸
下载PDF
Obeticholic acid for severe bile acid diarrhea with intestinal failure:A case report and review of the literature
2
作者 Christian Lodberg Hvas Peter Ott +3 位作者 Peter Paine simon lal Soren Peter Jorgensen Jens Frederik Dahlerup 《World Journal of Gastroenterology》 SCIE CAS 2018年第21期2320-2326,共7页
Bile acid diarrhea results from excessive amounts of bile acids entering the colon due to hepatic overexcretion of bile acids or bile acid malabsorption in the terminal ileum. The main therapies include bile acid sequ... Bile acid diarrhea results from excessive amounts of bile acids entering the colon due to hepatic overexcretion of bile acids or bile acid malabsorption in the terminal ileum. The main therapies include bile acid sequestrants, such as colestyramine and colesevelam, which may be given in combination with the opioid receptor agonist loperamide. Some patients are refractory to conventional treatments. We report the use of the farnesoid X receptor agonist obeticholic acid in a patient with refractory bile acid diarrhea and subsequent intestinal failure. A 32-year-old woman with quiescent colonic Crohn's disease and a normal terminal ileum had been diagnosed with severe bile acid malabsorption and complained of watery diarrhea and fatigue. The diarrhea resulted in hypokalemia and sodium depletion that made her dependent on twice weekly intravenous fluid and electrolyte infusions. Conventional therapies with colestyramine, colesevelam, and loperamide had no effect. Second-line antisecretory therapies with pantoprazole, liraglutide, and octreotide also failed. Third-line treatment with obeticholic acid reduced the number of stools from an average of 13 to an average of 7 per 24h and improved the patient's quality of life. The fluid and electrolyte balances normalized. The effect was sustained during follow-up for 6 mo with treatment at a daily dosage of 25 mg. The diarrhea worsened shortly after cessation of obeticholic acid. This case report supports the initial report that obeticholic acid may reduce bile acid production and improve symptoms in patients with bile acid diarrhea. 展开更多
关键词 BILE ACID MALABSORPTION DIARRHEA Farnesoid X-activated receptor Crohn’s disease
下载PDF
Diphyllobothrium latum:A case of an incidental finding
3
作者 simon lal A Hillary Steinhart 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第12期1875-1876,共2页
Colorectal cancer screening can be performed by fecal occult blood testing, sigmoidoscopy, double contrast barium enema or colonoscopy. Colonoscopy has the significant advantage that polyps can be removed during the s... Colorectal cancer screening can be performed by fecal occult blood testing, sigmoidoscopy, double contrast barium enema or colonoscopy. Colonoscopy has the significant advantage that polyps can be removed during the same procedure. Occasionally, colonoscopy can also reveal unexpected findings, including parasitic infections, even in asymptomatic patients. Tapeworms or cestodes are hermaphroditic parasites, which can live for considerable periods of time in the human gastrointestinal tract. Fish tapeworm (Diphyllobothrium species) are endemic in various parts of the world, the commonest species being Diphyllobothrium latum. Humans are the main definitive host for D. Latum and the majority of individuals harbouring the parasite are asymptomatic, while 40% of infected individuals may have low vitamin B12 levels. We describe a case of D. latum infection found on routine colonoscopic screening for colorectal cancer in an asymptomatic patient, which was successfully treated with praziquantel. The infection likely arose following raw fish (sushi) consumption. 展开更多
关键词 结肠镜检查 阔节裂头绦虫 寄生虫感染 偶然发现 病例报告
下载PDF
Management of intestinal failure in inflammatory bowel disease:Small intestinal transplantation or home parenteral nutrition?
4
作者 Elizabeth Harrison Philip Allan +3 位作者 Amrutha Ramu Anil Vaidya simon Travis simon lal 《World Journal of Gastroenterology》 SCIE CAS 2014年第12期3153-3163,共11页
Inflammatory bowel disease and Crohn’s disease in particular,is a common cause of intestinal failure.Current therapeutic options include home parenteral nutrition and intestinal transplantation.For most patients,home... Inflammatory bowel disease and Crohn’s disease in particular,is a common cause of intestinal failure.Current therapeutic options include home parenteral nutrition and intestinal transplantation.For most patients,home intravenous therapy including parenteral nutrition,with a good probability of long-term survival,is the favoured choice.However,in selected patients,with specific features that may shorten survival or complicate home parenteral nutrition,intestinal transplantation presents a viable alternative.We present survival,complications,quality of life and economic considerations that currently influence individualised decision-making between home parenteral nutrition and intestinal transplantation. 展开更多
关键词 INFLAMMATORY BOWEL DISEASE Crohn’s DISEASE Intesti
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部